Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Shruti Patrick, Kirti Lathoria, Vaishali Suri & Ellora Sen. (2023) Reduced YAP1 and FOLR1 in gliomas predict better response to chemotherapeutics. Cellular Signalling 109, pages 110738.
Crossref
Crossref
Diane D. Mao, Ryan T. Cleary, Amit Gujar, Tatenda Mahlokozera & Albert H. Kim. (2022) CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells. PLOS ONE 17:6, pages e0270251.
Crossref
Crossref
Magdalena Kusaczuk, Rafał Krętowski, Monika Naumowicz, Anna Stypułkowska & Marzanna Cechowska-Pasko. (2022) A Preliminary Study of the Effect of Quercetin on Cytotoxicity, Apoptosis, and Stress Responses in Glioblastoma Cell Lines. International Journal of Molecular Sciences 23:3, pages 1345.
Crossref
Crossref
Jaime Franco Pinto, Alexandra Fillion, Patricia Duchambon, Sophie Bombard & Anton Granzhan. (2022) Acridine–O6-benzylguanine hybrids: Synthesis, DNA binding, MGMT inhibition and antiproliferative activity. European Journal of Medicinal Chemistry 227, pages 113909.
Crossref
Crossref
Valerie J. Carpenter, Tareq Saleh & David A. Gewirtz. (2021) Senolytics for Cancer Therapy: Is All that Glitters Really Gold?. Cancers 13:4, pages 723.
Crossref
Crossref
Sang Y. Lee & Gaspar J. Kitange. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
79
133
.
M. Kolodziej, B. Al Barim, J. Nagl, M. Weigand, E. Uhl, F. Uhle, P. Di Fazio, F. Schwarm & M. Stein. (2020) Sphingosine‑1‑phosphate analogue FTY720 exhibits a�potent anti‑proliferative effect on glioblastoma cells. International Journal of Oncology.
Crossref
Crossref
Verena J. Herbener, Timo Burster, Alicia Goreth, Maximilian Pruss, Hélène von Bandemer, Tim Baisch, Rahel Fitzel, Markus D. Siegelin, Georg Karpel-Massler, Klaus-Michael Debatin, Mike-Andrew Westhoff & Hannah Strobel. (2020) Considering the Experimental Use of Temozolomide in Glioblastoma Research. Biomedicines 8:6, pages 151.
Crossref
Crossref
Ines Müller, Elwira Strozyk, Sebastian Schindler, Stefan Beissert, Htoo Zarni Oo, Thomas Sauter, Philippe Lucarelli, Sebastian Raeth, Angelika Hausser, Nader Al Nakouzi, Ladan Fazli, Martin E. Gleave, He Liu, Hans-Uwe Simon, Henning Walczak, Douglas R. Green, Jiri Bartek, Mads Daugaard & Dagmar Kulms. (2020) Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28. Molecular Cell 77:5, pages 970-984.e7.
Crossref
Crossref
Kaoru Ogawa, Akira Kurose, Akihisa Kamataki, Kenichiro Asano, Kosuke Katayama & Hidekachi Kurotaki. (2019) Giant cell glioblastoma is a distinctive subtype of glioma characterized by vulnerability to DNA damage. Brain Tumor Pathology 37:1, pages 5-13.
Crossref
Crossref
Natalia Fernández‐Bertólez, Carla Costa, Fátima Brandão, José Alberto Duarte, Joao Paulo Teixeira, Eduardo Pásaro, Vanessa Valdiglesias & Blanca Laffon. (2019) Evaluation of cytotoxicity and genotoxicity induced by oleic acid‐coated iron oxide nanoparticles in human astrocytes. Environmental and Molecular Mutagenesis 60:9, pages 816-829.
Crossref
Crossref
Natalia Fernández-Bertólez, Carla Costa, Fátima Brandão, Gözde Kiliç, José Alberto Duarte, Joao Paulo Teixeira, Eduardo Pásaro, Vanessa Valdiglesias & Blanca Laffon. (2018) Toxicological assessment of silica-coated iron oxide nanoparticles in human astrocytes. Food and Chemical Toxicology 118, pages 13-23.
Crossref
Crossref
Paulo Matheus Guerra Rodrigues, Roberto Salomon de Souza, Helena Lobo Borges & Rodrigo Alves Portela Martins. (2018) Regulation of c-Myc and NBS1 by ionizing radiation in glioblastoma cells. Oncology Signaling 1:1, pages 1-5.
Crossref
Crossref
Soliman Oushy, Justin E. Hellwinkel, Mary Wang, Ger J. Nguyen, Dicle Gunaydin, Tessa A. Harland, Thomas J. Anchordoquy & Michael W. Graner. (2017) Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype. Philosophical Transactions of the Royal Society B: Biological Sciences 373:1737, pages 20160477.
Crossref
Crossref
Laura Annovazzi, Marta Mellai & Davide Schiffer. (2017) Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma. Cancers 9:6, pages 57.
Crossref
Crossref
Pâmela Rossi Menegotto, Patrícia Luciana da Costa Lopez, Bárbara Kunzler Souza, Caroline Brunetto de Farias, Eduardo Cremonese Filippi-Chiela, Igor Araújo Vieira, Gilberto Schwartsmann, Guido Lenz & Rafael Roesler. (2016) Gastrin-Releasing Peptide Receptor Knockdown Induces Senescence in Glioblastoma Cells. Molecular Neurobiology 54:2, pages 888-894.
Crossref
Crossref
M. Kolodziej, C. Goetz, P. Di Fazio, R. Montalbano, M. Ocker, H. Strik & K. Quint. (2015) Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study. Oncology Reports.
Crossref
Crossref
Gisela Natalia Castro, Niubys Cayado-Gutiérrez, Felipe Carlos Martín Zoppino, Mariel Andrea Fanelli, Fernando Darío Cuello-Carrión, Mayra Sottile, Silvina Beatriz Nadin & Daniel Ramón Ciocca. (2014) Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells. Cell Stress and Chaperones 20:2, pages 253-265.
Crossref
Crossref
D. Meco, T. Servidei, G. Lamorte, E. Binda, V. Arena & R. Riccardi. (2014) Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models. Neuro-Oncology 16:8, pages 1067-1077.
Crossref
Crossref
Roxana Magaña-Maldonado, Karen Manoutcharian, Norma Y. Hernández-Pedro, Edgar Rangel-López, Verónica Pérez-De la Cruz, César Rodríguez-Balderas, Julio Sotelo & Benjamín Pineda. (2013) Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma. Journal of Cancer Research and Clinical Oncology 140:2, pages 291-301.
Crossref
Crossref
Ana P. Montaldi & Elza T. Sakamoto-Hojo. (2012) Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide. Clinical and Experimental Medicine 13:4, pages 279-288.
Crossref
Crossref
Massimo Nabissi, Maria Beatrice Morelli, Matteo Santoni & Giorgio Santoni. (2013) Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Carcinogenesis 34:1, pages 48-57.
Crossref
Crossref
Miguel A. Peña-Rico, María Nieves Calvo-Vidal, Ruth Villalonga-Planells, Fina Martínez-Soler, Pepita Giménez-Bonafé, Àurea Navarro-Sabaté, Avelina Tortosa, Ramon Bartrons & Anna Manzano. (2011) TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells. Radiotherapy and Oncology 101:1, pages 132-139.
Crossref
Crossref
Olga V. Leontieva & Mikhail V. Blagosklonny. (2010) DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging 2:12, pages 924-935.
Crossref
Crossref